These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 6187785)
1. Inhibition of 3',5'-cyclic nucleotide 3'-phosphohydrolase by a novel 1',2'-cyclic nucleotide. Nair V; Wiechert RJ; Young DA J Cyclic Nucleotide Res; 1982; 8(3):181-90. PubMed ID: 6187785 [No Abstract] [Full Text] [Related]
2. Inhibition of cyclic AMP phosphodiesterases by cyclic nucleotide analogs and nitrogen heterocycles. Miller JP; Sigman CC; Johnson HL; Novinson T; Springer RH; Senga K; O'Brien DE; Robins RK Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():277-90. PubMed ID: 6326528 [No Abstract] [Full Text] [Related]
3. Trapidil derivatives as potent inhibitors of cyclic AMP phosphodiesterase from heart and coronary arteries. Bartel S; Tenor H; Krause EG Biomed Biochim Acta; 1985; 44(5):K31-5. PubMed ID: 2415118 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator. Sakamoto N; Terai M; Takenaka T; Maeno H Biochem Pharmacol; 1978; 27(8):1269-74. PubMed ID: 81059 [No Abstract] [Full Text] [Related]
5. Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Structure-activity relationships. Van Inwegen RG; Salaman P; St Georgiev V; Weinryb I Biochem Pharmacol; 1979 Apr; 28(8):1307-12. PubMed ID: 87199 [No Abstract] [Full Text] [Related]
6. Griseolic acid, a cAMP phosphodiesterase inhibitor, and its ester: increase in cellular cAMP levels and reduction of intraocular pressure. Yamazaki M; Yasumoto T; Iijima Y; Yokoyama T; Fukami S; Kaneko M; Kiuchi Y; Mishima H Adv Second Messenger Phosphoprotein Res; 1990; 24():502-6. PubMed ID: 1698412 [No Abstract] [Full Text] [Related]
7. [Inhibition of cyclic nucleotide phosphodiesterase from rabbit heart by hydroxypyridines]. Polyansky NB; Smirnov LD; Shvedova AA; Kagan VE; Tkachuk VA Vopr Med Khim; 1983; 29(1):123-7. PubMed ID: 6301154 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of cyclic AMP phosphodiesterase activity and myocardial contractility: effects of cilostamide, a novel PDE inhibitor, and methylsiobutylxanthine on rabbit and canine ventricular muscle. Endoh M; Satoh K; Yamashita S Eur J Pharmacol; 1980 Aug; 66(1):43-52. PubMed ID: 6157546 [No Abstract] [Full Text] [Related]
15. [The relationship between the intracellular content of 1-methyl-3-isobutylxanthine and the permeability for water of the bladder wall in the frog]. Natochin IuV; Parnova RG; Firsov DL; Shakhmatova EI; Kaminskiĭ IuL Fiziol Zh SSSR Im I M Sechenova; 1989 Dec; 75(12):1766-71. PubMed ID: 2483381 [TBL] [Abstract][Full Text] [Related]
17. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues]. Medvedeva MV Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612 [TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis. Netherton SJ; Maurice DH Mol Pharmacol; 2005 Jan; 67(1):263-72. PubMed ID: 15475573 [TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of cyclic AMP phosphodiesterase by cortisol. Schmidtke J; Wienker T; Flügel M; Engel W Nature; 1976 Aug; 262(5569):593-4. PubMed ID: 183135 [No Abstract] [Full Text] [Related]
20. Negative regulation of cyclic AMP levels by activation of cyclic nucleotide phosphodiesterases: the example of the dog thyroid. Dumont JE; Miot F; Erneux C; Couchie D; Cochaux P; Gervy-Decoster C; Van Sande J; Wells JN Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():325-36. PubMed ID: 6202125 [No Abstract] [Full Text] [Related] [Next] [New Search]